FDA Restricts J&J’s COVID-19 Vaccine Due to Blood Clot Risk

WASHINGTON (AP) – U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.

The Food and Drug Administration said Thursday the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine.

The decision is the latest restriction to hit the company’s vaccine, which has long been overshadowed in the U.S. by the more effective shots from Pfizer and Moderna.

In December, the Centers for Disease Control and Prevention recommended using the Moderna and Pfizer shots over J&J’s because of its safety issues.

By Matthew Perrone and Lauran Neergaard, Associated Press

About Brendan Fitzpatrick

Brendan, a recent graduate from the University of Massachusetts Amherst, is one of the newest members of the CapeCod.com NewsCenter team. When not on the beat, you'll probably find him watching Boston sports.



CapeCod.com
737 West Main Street
Hyannis, MA 02601
Contact Us | Advertise Terms of Use 
Employment and EEO | Privacy